Table 2.

Bivariate Analysis between Characteristics of Treatment Charateristics and Secondary Complications to Treatment and Unsatisfaction with Body Image of Women

	Satisfied	Unsatisfied
	n (%)	n (%)	p*	PR (95% CI)
Multi-professional follow-up
No	3 (10.4)	26 (89.6)	0.009	1.30 (1.06-1.58)
Yes	23 (31.0)	51 (69.0)		1.00
Surgery technique
Non conservative	15 (33.4)	30 (66.6)	0.088	0.84 (0.67-1.05)
Conservative	10 (17.8)	46 (82.2)		1.00
Time of surgerya
Over 27 months	9 (18.7)	39 (81.3)	0.183	1.16 (0.93-1.45)
Between 6 and 26 months	16 (30.2)	37 (69.8)		1.00
Type of surgery
Non conservative	15 (33.4)	30 (66.6)		0.81 (0.63-1.03)
Conservative	10 (17.8)	40 (82.2)		1.00
Axillary approach
Axillary lymphadenectomy	16 (30.8)	36 (69.2)	0.192	0.86 (0.68-1.07)
No	10 (19.6)	41 (80.4)		1.00
Breast reconstruction
No	13 (21.7)	47 (78.3)	0.514	1.08 (0.85-1.36)
Yes	11 (27.5)	29 (72.5)		1.00
Neoadjuvant treatment
Yes	10 (45.5)	12 (54.5)	0.044	0.68 (0.45-1.01)
No	16 (20.0)	64 (80.0)		1.00
Adjuvant treatment
Yes	26 (25.3)	75 (74.3)	0.407	3.14 (0.71-1.39)
No	0 (0)	2 (100.0)		1.00
Early complications
Yes	8 (36.3)	14 (63.7)	0.176	0.81 (0.58-1.14)
No	18 (22.2)	63 (77.8)		1.00
Late complications
Yes	23 (32.0)	49 (68.0)	0.017	0.75 (0.61-0.91)
No	3 (9.6)	28 (93.3)		1.00
Necrosis/dehiscence
Yes	5 (83.3)	1 (16.7)	0.004	0.21 (0.03-1.27)
No	21 (21.7)	76 (78.3)		1.00
Seroma
Yes	6 (30.0)	14 (70.0)	0.585	0.92 (0.67-1.25)
No	20 (24.0)	63 (76.0)		1.00
Winged scapula
Yes	1 (25.0)	3 (75.0)	0.991	1.00 (0.56-1.78)
No	25 (25.3)	74 (74.7)		1.00
Lymphedema
Yes	17 (39.1)	14 (60.9)	0.082	0.51 (0.34-0.76)
No	9 (21.3)	63 (78.7)		1.00
Pain
Yes	18 (31.6)	39 (68.4)	0.099	0.82 (0.66-1.03)
No	8 (17.4)	38 (82.6)		1.00
Paresthesia
Yes	18 (36.0)	32 (64.0)	0.015	0.75 (0.04-0.40)
No	8 (0.15)	45 (85.0)		1.00

^*, p-values from chI² tests;

^a, The cutoff point was defined based on the median time since treatment; PR, prevalence ratio; CI, confidence interval